Table 2 Relative risk of renal cell cancer associated with standardised measured blood pressure and self reported blood pressure medication
From: Blood pressure and renal cancer risk: the HUNT Study in Norway
Women | Men | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Variable | Person years | Cases | RR a | 95% CI | P trend b | Person years | Cases | RR a | 95% CI | P trend b |
Systolic blood pressure (mm Hg) | ||||||||||
<130 | 304 754 | 13 | 1.0 | (Reference) | ’ | 200 863 | 31 | 1.0 | (Reference) | ’ |
130–149 | 145 513 | 26 | 1.7 | (0.9–3.5) | ’ | 223 960 | 40 | 0.8 | (0.5–1.4) | ’ |
150–169 | 73 828 | 24 | 2.0 | (0.9–4.2) | ’ | 81 183 | 35 | 1.2 | (0.7–2.0) | ’ |
⩾170 | 53 060 | 22 | 2.0 | (0.9–4.6) | 0.11 | 33 890 | 18 | 1.0 | (0.5–1.9) | 0.59 |
Diastolic blood pressure (mm Hg) | ||||||||||
<85 | 346 610 | 31 | 1.0 | (Reference) | ’ | 264 778 | 41 | 1.0 | (Reference) | ’ |
85–94 | 145 246 | 22 | 0.8 | (0.5–1.5) | ’ | 173 219 | 56 | 1.6 | (1.0–2.3) | ’ |
95–104 | 64 349 | 22 | 1.4 | (0.8–2.5) | ’ | 76 975 | 20 | 1.0 | (0.6–1.7) | ’ |
⩾105 | 20 950 | 10 | 1.6 | (0.8–3.5) | 0.13 | 24 924 | 7 | 0.9 | (0.4–2.0) | 0.49 |
Blood pressure medication c | ||||||||||
No | 504 135 | 57 | 1.0 | (Reference) | ’ | 499 677 | 106 | 1.0 | (Reference) | ’ |
Yes | 73 020 | 28 | 1.4 | (0.8–2.2) | ’ | 40 219 | 18 | 1.1 | (0.6–1.8) | ’ |